Effects of different intermittent peptide YY (3-36) dosing strategies on food intake, body weight, and adiposity in diet-induced obese rats

1 Department of Veterans Affairs, Nebraska Western Iowa Health Care System, Omaha; and 2 Biomedical Sciences Department, Creighton University, Omaha, Nebraska Submitted 20 January 2008 ; accepted in final form 11 June 2008 Chronic administration of anorexigenic substances to experimental animals by...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Regulatory, integrative and comparative physiology integrative and comparative physiology, 2008-08, Vol.295 (2), p.R449-R458
Hauptverfasser: Reidelberger, Roger D, Haver, Alvin C, Chelikani, Prasanth K, Buescher, James L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1 Department of Veterans Affairs, Nebraska Western Iowa Health Care System, Omaha; and 2 Biomedical Sciences Department, Creighton University, Omaha, Nebraska Submitted 20 January 2008 ; accepted in final form 11 June 2008 Chronic administration of anorexigenic substances to experimental animals by injections or continuous infusion typically produces either no effect or a transient reduction in food intake and body weight. Our aim here was to identify an intermittent dosing strategy for intraperitoneal infusion of peptide YY(3-36) [PYY(3-36)] that produces a sustained reduction in daily food intake and adiposity in diet-induced obese rats. Rats (665 ± 10 g body wt, 166 ± 7 g body fat) with intraperitoneal catheters tethered to infusion swivels had free access to a high-fat diet. Vehicle-treated rats ( n = 23) had relatively stable food intake, body weight, and adiposity during the 9-wk test period. None of 15 PYY(3-36) dosing regimens administered in succession to a second group of rats ( n = 22) produced a sustained 15–25% reduction in daily food intake for >5 days, although body weight and adiposity were reduced across the 9-wk period by 12% (594 ± 15 vs. 672 ± 15 g) and 43% (96 ± 7 vs. 169 ± 9 g), respectively. The declining inhibitory effect of PYY(3-36) on daily food intake when the interinfusion interval was 3 h appeared to be due in part to an increase in food intake between infusions. The declining inhibitory effect of PYY(3-36) on daily food intake when the interinfusion interval was < 3 h suggested possible receptor downregulation and tolerance to frequent PYY(3-36) administration; however, food intake significantly increased when PYY(3-36) treatments were discontinued for 1 day following apparent loss in treatment efficacies. Together, these results demonstrate the development of a potent homeostatic response to increase food intake when PYY(3-36) reduces food intake and energy reserves in diet-induced obese rats. gastrointestinal; peptide; intraperitoneal administration; anorexia; body composition Address for reprint requests and other correspondence: R. D. Reidelberger, VA-NWIHCS (151), 4101 Woolworth Ave., Omaha, NE 68105 (e-mail: roger.reidelberger{at}va.gov )
ISSN:0363-6119
1522-1490
DOI:10.1152/ajpregu.00040.2008